Marketing research of the national antiarrhythmic drugs market

Authors

  • T. P. Zarichna Zaporizhzhia State Medical University, Ukraine,
  • T. S. Raikova Zaporizhzhia State Medical University, Ukraine,
  • T. S. Brytanova Zaporizhzhia State Medical University, Ukraine,
  • Assani Doshi Rainna Zaporizhzhia State Medical University, Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2019.2.171073

Keywords:

pharmaceutical preparations, pharmaceutical market, drug industry, competition

Abstract

 

The purpose – marketing research of the national antiarrhythmic drugs market.Materials and methods. The State Register of Medicinal Products of Ukraine and Compendium-2019 were used as the research materials. Methods of system, marketing, statistical and content analysis. Results. The analysis of the range of antiarrhythmic drugs was conducted according to such criteria as composition, release form and originality. It showed the heterogeneity of this segment of Ukrainian pharmaceutical market. Thus, solid and liquid dosage forms, both original and generic could be found in the market. The analysis of the company structure of the studied market segment allowed to establish, that domestic pharmaceutical companies supply only 48 % of drugs (13 dosage forms) for this market segment, while foreign pharmaceutical companies prevail (52 %). In this connection, the development of new medicinal products of the specified activity and the mastering of their production on the territory of Ukraine is relevant. The calculated tension coefficient showed that the highest competition is observed among manufacturers of analog preparations containing amiodarone hydrochloride (Кvi = 0.93). Also, the specific weight of each of the manufacturers of antiarrhythmic drugs was calculated and it was established, that (LLC) Pharmaceutical Company Zdorovye has the largest share (dij = 0.1481).Conclusions. Conducted marketing studies of the range of the national antiarrhythmic drugs market showed the heterogeneity of this segment in terms of dosage forms and originality of drugs. The analysis of the company structure has established a high level of competition among the leading foreign pharmaceutical companies, whose share is 52 %. The coefficient of tension and the share of the segment, of each manufacturers of antiarrhythmic drugs, was calculated. 

References

Kompendium – lekarstvennye preparaty [Compendium – Drugs]. Retrieved from http://compendium.com.ua/. [in Russian].

Derzhavnyi reiestr likarskykh zasobiv Ukrainy [State register of medicines Ukraine]. Retrieved from http://www.drlz. kiev.ua/ [in Ukrainian].

Miakinkova, L. O. (2013). Osoblyvostі zastosuvannia antyarytmіchnykh preparatіv [Antiarrythmic drugs: peculiarities of usage]. Bukovynskyi medychnyi visnyk, 17, 3(67), 2, 164–168. [in Ukrainian].

Mnushko, Z. M., & Popova, Yu. V. (2007). Metodyky otsіnky rіvnia konkurentospromozhnostі lіkarskykh preparatіv [Methods of assessing the level of competitiveness of medicinal products]. Kharkiv: NFaU. [in Ukrainian].

Kukhtenko, O. S., Simonyan, L. S., & Нladukh, Ye. V. (2017) Marketynhovі doslіdzhennia rynku lіkarskykh zasobіv, shho zastosovuiutsia pry lіkuvannі kardіolohіchnykh zakhvoriuvan [Market research of medicinal products which are used in cardiological diseases treatment]. Current issues in pharmacy and medicine: science and practice, 2(24), 219–223 [in Ukrainian]. doi: 10.14739/2409-2932.2017.2.103783

Downloads

How to Cite

1.
Zarichna TP, Raikova TS, Brytanova TS, Doshi Rainna A. Marketing research of the national antiarrhythmic drugs market. Current issues in pharmacy and medicine: science and practice [Internet]. 2019Jun.24 [cited 2024Dec.23];(2). Available from: http://pharmed.zsmu.edu.ua/article/view/171073

Issue

No. 2 (2019)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)